Evidence map›Paper›PMID 39541438›Full record

ArticleJCI insight2024

Recurrent small variants in NESP55/NESPAS associated with broad GNAS methylation defects and pseudohypoparathyroidism type 1B.

Dong Li, Suzanne Jan de Beur, Cuiping Hou, Maura Rz Ruzhnikov, Hilary Seeley, Garry R Cutting, Molly B Sheridan, Michael A Levine

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Bidirectional disruption ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dong LiCenter for Applied Genomics, and.
Suzanne Jan de BeurDivision of Endocrinology and Metabolism, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Cuiping HouCenter for Applied Genomics, and.
Maura Rz RuzhnikovNeurology and Neurological Sciences, Pediatrics, Division of Medical Genetics, and.
Hilary SeeleyDivision of Pediatric Endocrinology, Stanford University and Lucile Packard Children's Hospital, Palo Alto, California, USA.
Garry R CuttingDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Molly B SheridanDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Michael A LevineDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Funding

Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1R01DK112955 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael A. Levine, David R Weber · 2017 to 2026
$5.1M
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENER01DK056178 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LEVINE, MICHAEL ALAN · 1999 to 2003
$1.6M
NIDDK NIH HHS R01 DK056178NIDDK NIH HHS R01 DK112955
6 · The paper itself

Abstract

Pseudohypoparathyroidism type 1B (PHP1B) is associated with epigenetic changes in the maternal allele of the imprinted GNAS gene that inhibit expression of the α subunit of Gs (Gsα), thereby leading to parathyroid hormone resistance in renal proximal tubule cells where expression of Gsα from the paternal GNAS allele is normally silent. Although all patients with PHP1B show loss of methylation for the exon A/B differentially methylated region (DMR), some patients with autosomal dominant PHP1B (AD-PHP1B) and most patients with sporadic PHP1B have additional methylation defects that affect the DMRs corresponding to exons XL, AS1, and NESP. Because the genetic defect is unknown in most of these patients, we sought to identify the underlying genetic basis for AD-PHP1B in 2 multigenerational families with broad GNAS methylation defects and negative clinical exomes. Genome sequencing identified small GNAS variants in each family that were also present in unrelated individuals with PHP1B in a replication cohort. Maternal transmission of one GNAS microdeletion showed reduced penetrance in some unaffected patients. Expression of AS transcripts was increased, and NESP was decreased, in cells from affected patients. These results suggest that the small deletion activated AS transcription, leading to methylation of the NESP DMR with consequent inhibition of NESP transcription, and thereby provide a potential mechanism for PHP1B.

Indexed as

ChromograninsDNA MethylationGTP-Binding Protein alpha Subunits, GsPseudohypoparathyroidismAdultChildEpigenesis, GeneticFemaleGenomic ImprintingHumansMalePedigreeChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsBone diseaseEndocrinologyGenetic diseasesGeneticsMolecular diagnosis

Identifiers

PMID39541438
PMCPMC11665564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.